{"id":"https://openalex.org/W2007345907","doi":"https://doi.org/10.1055/s-0031-1296425","title":"Pharmacokinetics of Isoxsuprine Hydrochloride Administered Orally and Intramuscularly to Female Healthy Volunteers","display_name":"Pharmacokinetics of Isoxsuprine Hydrochloride Administered Orally and Intramuscularly to Female Healthy Volunteers","publication_year":2011,"publication_date":"2011-12-13","ids":{"openalex":"https://openalex.org/W2007345907","doi":"https://doi.org/10.1055/s-0031-1296425","mag":"2007345907","pmid":"https://pubmed.ncbi.nlm.nih.gov/19856793"},"language":"en","primary_location":{"id":"doi:10.1055/s-0031-1296425","doi":"https://doi.org/10.1055/s-0031-1296425","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0031-1296425","pdf_url":null,"source":{"id":"https://openalex.org/S132758211","display_name":"Arzneimittelforschung","issn_l":"0004-4172","issn":["0004-4172","1616-7066"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittelforschung","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112814876","display_name":"A Marzo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Antonio Marzo","raw_affiliation_strings":["I.P.A.S. SA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"I.P.A.S. SA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033508316","display_name":"Dario Zava","orcid":"https://orcid.org/0000-0002-8218-5517","observed_orcids":["https://orcid.org/0000-0002-8218-5517"]},"institutions":[{"id":"https://openalex.org/I4210129952","display_name":"Lusofarmaco (Italy)","ror":"https://ror.org/03ncmjy81","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210129952"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Dario Zava","raw_affiliation_strings":["Istituto Lusofarmaco D\u2019Italia S.p.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Lusofarmaco D\u2019Italia S.p.A","institution_ids":["https://openalex.org/I4210129952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075761643","display_name":"Katrin Coa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katrin Coa","raw_affiliation_strings":["I.P.A.S. SA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"I.P.A.S. SA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100511870","display_name":"Lorenzo Bo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lorenzo Bo","raw_affiliation_strings":["I.P.A.S. SA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"I.P.A.S. SA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079500487","display_name":"Shefqet Ismaili","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shefqet Ismaili","raw_affiliation_strings":["I.P.A.S. SA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"I.P.A.S. SA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073240685","display_name":"Simona Tavazzi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simona Tavazzi","raw_affiliation_strings":["I.P.A.S. SA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"I.P.A.S. SA","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Vittorio Cantoni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129952","display_name":"Lusofarmaco (Italy)","ror":"https://ror.org/03ncmjy81","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210129952"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vittorio Cantoni","raw_affiliation_strings":["Istituto Lusofarmaco D\u2019Italia S.p.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Lusofarmaco D\u2019Italia S.p.A","institution_ids":["https://openalex.org/I4210129952"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5112814876"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6521,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.63598088,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"59","issue":"09","first_page":"455","last_page":"460"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.600600004196167,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.600600004196167,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.19670000672340393,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.07069999724626541,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/isoxsuprine-hydrochloride","display_name":"isoxsuprine hydrochloride","score":0.9570000171661377},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9769999980926514},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.8640000224113464},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.8610000014305115},{"id":"https://openalex.org/keywords/intramuscular-administration","display_name":"intramuscular administration","score":0.9940000176429749},{"id":"https://openalex.org/keywords/beta-adrenergic-stimulation","display_name":"beta-adrenergic stimulation","score":0.7390000224113464},{"id":"https://openalex.org/keywords/peripheral-vasodilation","display_name":"peripheral vasodilation","score":0.828000009059906},{"id":"https://openalex.org/keywords/urinary-excretion","display_name":"urinary excretion","score":0.7080000042915344},{"id":"https://openalex.org/keywords/free-drug","display_name":"free drug","score":0.39800000190734863},{"id":"https://openalex.org/keywords/drug-absorption","display_name":"drug absorption","score":0.5170000195503235},{"id":"https://openalex.org/keywords/zero-order-release","display_name":"zero-order release","score":0.5630000233650208},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.625},{"id":"https://openalex.org/keywords/heart-rate","display_name":"heart rate","score":0.5799999833106995},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.5860000252723694},{"id":"https://openalex.org/keywords/healthy-female-volunteers","display_name":"healthy female volunteers","score":0.5090000033378601}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7831227779388428},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5726501941680908},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.5586540699005127},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4499814808368683},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42895767092704773},{"id":"https://openalex.org/C2779350572","wikidata":"https://www.wikidata.org/wiki/Q784720","display_name":"Sublingual administration","level":2,"score":0.4127485752105713},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37577515840530396},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.36514490842819214},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3259769678115845},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.2422989308834076},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000318","descriptor_name":"Adrenergic beta-Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000318","descriptor_name":"Adrenergic beta-Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000318","descriptor_name":"Adrenergic beta-Agonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007273","descriptor_name":"Injections, Intramuscular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007556","descriptor_name":"Isoxsuprine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007556","descriptor_name":"Isoxsuprine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007556","descriptor_name":"Isoxsuprine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1055/s-0031-1296425","doi":"https://doi.org/10.1055/s-0031-1296425","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0031-1296425","pdf_url":null,"source":{"id":"https://openalex.org/S132758211","display_name":"Arzneimittelforschung","issn_l":"0004-4172","issn":["0004-4172","1616-7066"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittelforschung","raw_type":"journal-article"},{"id":"pmid:19856793","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19856793","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittel-Forschung","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2040456296","https://openalex.org/W1961153804","https://openalex.org/W2123523801","https://openalex.org/W4402534835","https://openalex.org/W2316157242","https://openalex.org/W2409557757","https://openalex.org/W3024418679","https://openalex.org/W2025421891","https://openalex.org/W1903755941","https://openalex.org/W6903496799"],"abstract_inverted_index":{"Isoxsuprine":[0],"(1-(4-hydroxyphenyl)-2-(1-methyl-2-phenoxyethylamino)-1-propanol,":[1],"CAS":[2],"395-28-8)":[3],"is":[4,32],"a":[5,15,107,188],"peripheral":[6],"vasodilator":[7],"that":[8,105,182,258],"also":[9],"stimulates":[10],"beta-adrenergic":[11,308],"receptors.":[12,309],"It":[13,31],"causes":[14],"direct":[16],"relaxation":[17],"of":[18,43,51,68,94,111,156,171,183,191,207,240,247,256,307,312],"vascular":[19],"and":[20,24,28,39,71,91,96,122,124,165,209,211,268,282],"uterine":[21],"smooth":[22],"muscles":[23],"produces":[25],"positive":[26],"inotropic":[27],"chronotropic":[29],"effects.":[30],"widely":[33],"used":[34],"to":[35,47,56,75,176,213,231,303,315],"arrest":[36],"premature":[37],"labour":[38],"miscarriage.":[40],"The":[41,135,168,227,310],"aim":[42],"this":[44],"trial":[45],"was":[46,88,138,160,200,259,298],"investigate":[48],"the":[49,66,132,150,157,172,192,203,223,237,241,245,248,265,273,285,292,304,321],"pharmacokinetics":[50],"isoxsuprine":[52,98,278,313],"hydrochloride":[53],"administered":[54],"orally":[55],"healthy":[57],"young":[58],"female":[59],"volunteers":[60],"as":[61,234],"an":[62,153,299],"extended-release":[63,249],"formulation":[64],"at":[65],"doses":[67,225],"30,":[69],"60":[70],"90":[72],"mg":[73,77],"compared":[74],"10":[76,270],"by":[78,101,131],"i.m.":[79,144,266,283],"route.":[80],"A":[81],"randomised,":[82],"crossover,":[83],"four-period,":[84],"multisequence,":[85],"single-dose":[86],"design":[87],"adopted.":[89],"Plasma":[90],"urine":[92,126,166],"concentrations":[93,116],"free":[95,136,173,193],"total":[97,147,184],"were":[99,129],"evaluated":[100,130,201],"tandem":[102],"mass":[103],"spectrometry":[104],"reached":[106],"low":[108],"quantification":[109],"limit":[110],"1":[112],"ng/ml.":[113],"From":[114],"plasma":[115,142,164],"Cmax,":[117],"tmax,":[118],"AUC(0-t),":[119],"AUC(0-infinity),":[120],"t1/2":[121],"Vd":[123],"from":[125,202,236,244,289],"concentration":[127],"CUE(0-24h)":[128],"non-compartmental":[133],"model.":[134],"drug":[137,151,174,194,242],"present":[139],"only":[140],"in":[141,162],"after":[143,152,264,272],"route,":[145],"whereas":[146],"isoxsuprine,":[148,185],"namely":[149],"enzymatic":[154],"hydrolysis":[155],"conjugate":[158],"form,":[159],"detected":[161],"all":[163,320],"samples.":[167],"distribution":[169],"volume":[170],"proved":[175,212,230,314],"be":[177,214,232,316],"2.5":[178],"times":[179],"higher":[180],"than":[181],"which":[186],"indicates":[187],"good":[189,318],"penetration":[190],"into":[195],"tissue":[196],"compartments.":[197],"Oral":[198],"absorption":[199,229],"p.o./i.m.":[204],"percentualized":[205],"ratio":[206],"AUC":[208],"CUE":[210],"on":[215,260],"average":[216,261],"around":[217,269],"51%,":[218],"being":[219],"linearly":[220],"correlated":[221],"with":[222,319],"three":[224,274],"administered.":[226],"oral":[228,275,281],"sustained":[233],"expected":[235,300],"zero-order":[238],"kinetics":[239],"release":[243],"core":[246],"formulation.":[250],"This":[251,297],"has":[252],"justified":[253],"different":[254],"values":[255],"half-life":[257],"2.2":[262],"h":[263,271,294],"route":[267],"doses.":[276],"After":[277],"administration,":[279],"both":[280],"routes,":[284],"heart":[286],"rate":[287],"increased":[288],"baseline":[290],"during":[291],"9":[293],"monitoring":[295],"period.":[296],"finding":[301],"attributable":[302],"stimulating":[305],"activity":[306],"tolerability":[311],"very":[317],"four":[322],"administrations":[323],"performed.":[324]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}